Correction to: Oncogene https://doi.org/10.1038/s41388-024-03007-2, published online 20 March 2024
In the Acknowledgements of this article the funding source National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54AR081774) was missing.
The Acknowledgements should be read:
We thank all members of the Wirtz Lab for discussions and feedback on this project. We also thank Alan Meeker and Sujayita Roy from the Oncology Tissue Services IHC Core at Johns Hopkins Medical Campus for their assistance with IHC. This work was supported through grants from the National Cancer Institute (U54CA143868, UG3CA275681, and U54CA268083), the National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54AR081774), and the National Institute on Aging (U01AG060903) to DW and PHW.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Russo, G.C., Crawford, A.J., Clark, D. et al. Correction: E-cadherin interacts with EGFR resulting in hyper-activation of ERK in multiple models of breast cancer. Oncogene (2024). https://doi.org/10.1038/s41388-024-03023-2
Published:
DOI: https://doi.org/10.1038/s41388-024-03023-2
